Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy
Description
The perioperative therapeutic landscape for early-stage resectable NSCLC is advancing rapidly. Are you up to date?
Credit available for this activity expires: 22/11/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998570?ecd=bdc_podcast_libsyn_mscpedu
What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them?
Credit available for this activity expires: 06/28/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/28/24
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice?
Credit available for this activity expires: 6/27/25
Earn Credit / Learning Objectives & Disclosures:...
Published 06/27/24